论文部分内容阅读
目的:研究孟鲁司特钠在儿科哮喘治疗中的临床应用。方法:选取我院2013年2月~2014年2月治疗的哮喘患儿82例,随机分为观察组45例和对照组37例,给以对照组常规哮喘治疗方法,而观察组在常规治疗基础之上加以孟鲁司特钠辅助治疗,观察并比较治疗效果及治疗后3周、7周内的哮喘发作次数。结果:观察组45例患儿在接受治疗后,其总有效率为95.5%;对照组总有效率为75.7%。观察组患儿治疗总有效率明显高于对照组,组间治疗效果比较具有明显差异,P<0.05。结论:孟鲁司特钠在儿科哮喘治疗中的临床应用较为广泛,对患儿治疗效果较好且口服方便,较大程度上缩减了患儿病痛时间,促进患儿较快恢复健康。
Objective: To study the clinical application of montelukast sodium in the treatment of pediatric asthma. Methods: Eighty-two children with asthma who were treated in our hospital from February 2013 to February 2014 were randomly divided into observation group (n = 45) and control group (n = 37). The control group received conventional asthma treatment, while the observation group received conventional treatment On the basis of montelukast sodium adjuvant therapy to observe and compare the treatment effect and the treatment of 3 weeks, 7 weeks the number of asthma attacks. Results: In the observation group, the total effective rate was 95.5% in 45 children after receiving treatment; the total effective rate in the control group was 75.7%. The total effective rate of treatment group was significantly higher than that of the control group, and there was significant difference between the two groups (P <0.05). Conclusion: The clinical application of montelukast sodium in the treatment of pediatric asthma is more extensive. It has good curative effect and oral convenience for children, reduces the time of illness and pain in children to a large extent, and promotes the quick recovery of children ’s health.